As leader of the global Simcyp PBPK services team, Hannah is passionate about using modeling approaches to make drug development more efficient and get better drugs to patients more quickly, ultimately saving patient lives. Hannah has over 20 years of experience in global organizations with a background in translational sciences. She has experience working in a range of modalities from small molecules to biologics, and cell and gene therapies across many therapeutic areas. She has over 70 publications in PBPK and PKPD modeling and other DMPK related topics. She was featured in the list of the top 2% of scientists worldwide by Elsevier BV and Stanford University from 2019-2024.